(Q51010262)

27 March 2018

title

Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. (English)

1 reference

27 March 2018

main subject

osteogenesis imperfecta

1 reference

Antoniazzi F

1

1 reference

27 March 2018

Bertoldo F

2

1 reference

27 March 2018

Mottes M

3

1 reference

27 March 2018

Valli M

4

1 reference

27 March 2018

Sirpresi S

5

1 reference

27 March 2018

Zamboni G

6

1 reference

27 March 2018

Valentini R

7

1 reference

27 March 2018

Tató L

8

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 September 1996

1 reference

27 March 2018

The Journal of Pediatrics

published in

1 reference

27 March 2018

volume

129

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

432-439

1 reference

27 March 2018

Genetic heterogeneity in osteogenesis imperfecta

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Insulin-like growth factor I has independent effects on bone matrix formation and cell replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Osteogenesis imperfecta: A clinical study of the first ten years of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Bone mineral content and density in healthy subjects and in osteogenesis imperfecta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

New approaches for interpreting projected bone densitometry data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Effects of human growth hormone in men over 60 years old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Turner syndrome adolescents receiving growth hormone are not osteopenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Hypercalciuria in osteogenesis imperfecta: a follow-up study to assess renal effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

7 January 2021

Growth Hormone and Bone

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

On an Attempt to Treat Primary and Secondary Osteoporosis with Human Growth Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Plasma osteocalcin levels in patients with osteogenesis imperfecta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis imperfecta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Osteocalcin levels in osteogenesis imperfecta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970077-X

10.1016/S0022-3476(96)70077-X

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

8804334

1 reference

27 March 2018